News
Press Release
Axplora invests €8 million in Le Mans to further expand its capacity for antibody drug conjugate manufacturing
Axplora strengthens its innovative position in oncology to enable cancer care for patients: €8M investment on its Le Mans (Fr) site, with the support of the France 2030 program, to expand its production capabilities for the manufacturing of ADCs, offering high-quality services for our customers and cutting-edge drugs for millions of patients worldwide. Read the full press release to know more!
Press Release
Axplora announces the appointment of its Scientific Advisory Board
Press Release
Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit
Press Release
Farmabios, an Axplora company, granted cGMP approval from AIFA for extended production capacity in HPAPIs and Steroids
Press Release
A new cGMP pilot facility for flow chemistry
Press Release